A Comparative Study Between Mechanical and a Viscoelastic Disc Prosthesis in the Lumbar Spine
Degenerative Disc Disease, Discogenic Low Back Pain
About this trial
This is an interventional treatment trial for Degenerative Disc Disease focused on measuring Clinical outcome, Mobility, Facet-joints
Eligibility Criteria
Inclusion Criteria:
- Incapacitating pain from DDD (both clinical and radiological) in one or two segments below the L3 vertebra, were at least one segment is suitable for TDR treatment.
- Patient with more than one year of pain, that has during this period made a prolonged and adequate conservative program.
-Patient between 20 and 55 years of age. -
-Patient able to understand written and spoken Swedish.
Exclusion Criteria:
- Patient does not accept to be part of the study.
- Three or more segments suspected to be symptomatic.
- Earlier vertebral fracture, tumour, infection or fusion in the lumbar spine. -Substantial scoliosis/deformity.
- Need for posterior decompression.
- Pregnancy, psychiatric illness or drug abuse. -Patient does not understand written and spoken Swedish and can thus not take part in information and answer questionnaires.
-Patient residing outside Sweden and thus is not covered with SweSpine. -
Sites / Locations
- Stockholm Spine Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Active Comparator
Experimental
ORBIT Mechanical disc prosthesis
ZACK viscoelastic disc prosthesis
ORBIT SASCA
ZACK SASCA
Surgical procedure with total disc replacement using mechanical disc prosthesis device, "ORBIT, Globus Medical"
Surgical procedure with total disc replacement using viscoelastic disc prosthesis device, "ZACK, FH Orthopaedics"
Surgical procedure with total disc replacement (TDR) using ORBIT disc prostheses device combined with adjacent level anterior intracorporal fusion (ALIF) with intracorporal device SASCA.
Surgical procedure with total disc replacement (TDR) using ZACK disc prostheses device combined with adjacent level anterior intracorporal fusion (ALIF) with intracorporal device SASCA.